FDA Approves the First Anti-VEGF Port Delivery System for Diabetic Macular Edema
Got a patient with DME? Say goodbye to the monthly jab—Susvimo, the first continuous drug delivery system for DME just…
A New Dawn for Retinal Care
From biosimilars and gene therapies to bionic eyes, the next era of retinal care is poised to be game-changing For…
latest posts
